Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.
about
Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection modelPharmacodynamic analysis of the activity of quinupristin-dalfopristin against vancomycin-resistant Enterococcus faecium with differing MBCs via time-kill-curve and postantibiotic effect methods.Use of vancomycin pharmacokinetic-pharmacodynamic properties in the treatment of MRSA infectionsCerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit.Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized studyImpaired target site penetration of vancomycin in diabetic patients following cardiac surgery.How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?Vancomycin penetration of uninfected pleural fluid exudate after continuous or intermittent infusion.Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model.Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database reviewNew Regimen for Continuous Infusion of Vancomycin in Critically Ill Patients.Evaluation of double- and triple-antibiotic combinations for VIM- and NDM-producing Klebsiella pneumoniae by in vitro time-kill experiments.Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.Initial vancomycin dosing recommendations for critically ill patients undergoing continuous venovenous hemodialysis.Comparison of Continuous and Intermittent IV Infusion of Vancomycin: Systematic Review.Incidence and risk factors of acute kidney injury associated with continuous intravenous high-dose vancomycin in critically ill patients: A retrospective cohort study.Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureusInfluence of vancomycin infusion methods on endothelial cell toxicity.Biofilm infections between Scylla and Charybdis: interplay of host antimicrobial peptides and antibiotics.
P2860
Q33593883-516018B6-E7D9-4B58-B9D6-30800B587AE1Q33695596-E55C7F43-1A90-4B24-B8FB-3A0C033CA6D2Q33881584-C243995D-0F1D-41B8-874A-2D2D09E6143BQ33979524-BA746441-8653-4EF9-957E-DC5562CDB149Q33982863-EAAFE86A-3A76-4945-A6C0-BCBD1422B03BQ34510414-399C0460-471C-4FEB-8D7F-FEE1401C9C24Q34894900-6E97A54E-0F2D-4431-AD03-6FEE5C66644FQ35013838-F4488905-A378-4CBB-A493-3BA3C3ECB15AQ35138007-554EF736-018D-4C89-83CB-5C6836B6942EQ36290499-9612E1A9-B1C5-45CF-BCC6-9618C06C69BFQ37120168-A2450957-6A3D-44D2-810C-152FC01443B7Q37643655-6B5BECC0-7C02-427C-84A5-8C8A8DB8F52AQ37712974-2552E66E-85B8-49F8-89CA-5DAF2AE73A33Q38000242-02F3E44E-9F1D-46B8-BE81-41CB2984F9DEQ38000245-CE7B95DF-89BD-4461-A668-85860ED2F2F6Q40330013-CBF958A6-DCDB-43A8-89EE-0E9A7569EC13Q40903164-9065EF5B-30DD-4943-B842-0F9E57B30DA4Q43156951-769D4F33-4114-4C35-84B2-97DE6087ED4FQ52314954-1D8C6374-34C6-4C82-B89E-D0A09FD345F2
P2860
Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.
description
1996 nî lūn-bûn
@nan
1996 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի մարտին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
name
Comparison of conventional dos ...... nted gram-positive infections.
@ast
Comparison of conventional dos ...... nted gram-positive infections.
@en
type
label
Comparison of conventional dos ...... nted gram-positive infections.
@ast
Comparison of conventional dos ...... nted gram-positive infections.
@en
prefLabel
Comparison of conventional dos ...... nted gram-positive infections.
@ast
Comparison of conventional dos ...... nted gram-positive infections.
@en
P2093
P2860
P1476
Comparison of conventional dos ...... nted gram-positive infections.
@en
P2093
P2860
P304
P407
P577
1996-03-01T00:00:00Z